Recherche
-
Outcome prediction with a social cognitive battery: a multicenter longitudinal study
(npj Schizophrenia. vol. 7, n° 1, 2021-05-26)Article de revueLibre accès -
Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
(Frontiers in Psychiatry. vol. 13, 2022-07-01)Article de revueLibre accès -
Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode
(Journal of Affective Disorders. vol. 264, pp. 318-323, 2020-03-01)Article de revueLibre accès -
Axo-axonic cells in neuropsychiatric disorders: a systematic review.
(Frontiers in Cellular Neuroscience. vol. 17, 2023-06-26)Article de revueLibre accès -
Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohort.
(Journal of Affective Disorders. vol. 274, pp. 617-623, 2020-09-01)Article de revueLibre accès -
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome
(BMC Cardiovascular Disorders. vol. 15, pp. 23, 2015-03-18)Article de revueLibre accès -
Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates
(Brain, Behavior, and Immunity. vol. 94, pp. 104-110, 2021-05)Article de revueLibre accès -
Treatment-resistant depression in a real-world setting: first interim analysis of characteristics, healthcare resource use, and utility values of the fondaMental cohort
(Brain Sciences. vol. 10, n° 12, pp. 1-16, 2020-12-10)Article de revueLibre accès -
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
(Molecular Psychiatry. vol. 27, n° 3, pp. 1286-1299, 2021-12)Article de revueLibre accès -
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort
(European Neuropsychopharmacology. vol. 77, pp. 67-79, 2023-12-01)Article de revueLibre accès